SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Debt | ₹258 Cr | ₹47 Cr | ₹0.05 Cr |
What is the latest Total Debt ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹258 Cr |
| Mar2024 | ₹47 Cr |
| Mar2023 | ₹0.05 Cr |
How is Total Debt of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹258 Cr | 449.33 | |
| Mar2024 | ₹47 Cr | 92,056.86 | |
| Mar2023 | ₹0.05 Cr | - | |
Compare Total Debt of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹8,050.8 Cr | -8.3% | 11.1% | 64.9% | Stock Analytics | |
| PRIME FOCUS | ₹21,143.8 Cr | 17.3% | 14.5% | 65.8% | Stock Analytics | |
| SAGILITY | ₹19,619.4 Cr | 3.8% | 3.5% | 1.6% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,923.8 Cr | 2.5% | -8.6% | -33.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,851.2 Cr | 1.8% | -6.2% | -11.8% | Stock Analytics | |
| INDEGENE | ₹12,218.5 Cr | 2.6% | -0.8% | -9.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -8.3% |
11.1% |
64.9% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses